Dr. Ginsburg Addresses Global Disparities in Cervical Cancer

Video

In Partnership With:

Ophira Ginsburg, MD, director of the High Risk/Cancer Genetics Program at NYU Langone's Perlmutter Cancer Center, addresses global disparities in cervical cancer.

Ophira Ginsburg, MD, director of the High Risk/Cancer Genetics Program at NYU Langone's Perlmutter Cancer Center, addresses global disparities in cervical cancer.

Until now, many countries have been understandably reluctant to allocating resources toward cancer, as it has historically been seen as an expensive disease to treat, and almost impossible to prevent, says Ginsburg.

There are many opportunities to tackle cervical cancer control in low- and middle-income countries that may not be obvious, says Ginsburg. The first option is to improve the health system for cancer care more broadly, such as teaching the importance of radiotherapy and brachytherapy. It is important to include these technologies, infrastructures, resources, and training in order to address the cancer burden as a whole in these countries. Once that is done, preventing or treating a disease such as cervical cancer, which is relatively well controlled in the first-world, will be an easier task.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD